• Search Funds
  • Model Portfolios
  • Provider
  • Sector
  • Manager

Search by provider name

Search by sector name

Search by manager name

Search by Risk Level

AXA Framlington Biotech Fund Z Acc

  • Fund Info & charges
  • Performance
  • Fund breakdown
  • Dividend History
Fund Provider AXA Investment Managers UK Ltd
Fund Summary The aim of this Fund is to provide long-term capital growth.
SEDOL code B784NS1
ISIN GB00B784NS11
Fund code FMBTA
Managers Linden Thomson, Dani Saurymper
Manager Tenure 8 years
Morningstar Category Sector Equity Biotechnology
IMA Sector Specialist
Fund Size £491 million
Fund Type OEIC
Management Style Active
Ongoing Charge Figure (OCF) 0.82%
Cavendish ongoing charge 0.05%
FundsNetwork Service Fee 0.20%
Minimum Initial Investment £25
Minimum Top Up £25
Minimum Monthly Investment £25
Sell Price £4.6590
Buy Price £4.6590
Price Change +1.0849%
Price Date 3rd July 2020
Yield Currently unavailable
Dividend Frequency Semi-Annually
ISA Eligible Yes
SIPP Eligible Yes
Inception Date 29th May 2013
Fund Status OPEN

3-year Mean Monthly Return: 1.215%

Annual Returns 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Fund Performance +33.23% +1.05% +7.85% +27.17% -21.98% +56.18% +33.86% +40.87% +22.02% +23.29%
Benchmark Performance
(Sector Equity Biotechnology)
+27.65% +0.14% +3.67% +26.30% -16.68%
Time Period Cumulative Benchmark Performance
(Sector Equity Biotechnology)
Fund Compared to Benchmark
1 day 1.08% +22.80% -21.72%
1 week -0.55% +4.90% -5.46%
1 month 4.56% +30.68% -26.13%
3 months 30.43% +22.97% +7.46%
6 months 31.50% +26.12% +5.38%
1 year 31.05% +13.28% +17.77%
3 years 13.89% +9.15% +4.74%
5 years 7.23% +19.62% -12.39%
10 years 20.50% +8.62% +11.88%
YTD 31.17% -0.41% +31.58%
Since inception 9.58% Currently unavailable Currently unavailable

Top 10 shares for this fund

Share Name Country Value
Regeneron Pharmaceuticals Inc USA 7.78%
Amgen Inc USA 7.00%
Biogen Inc USA 6.58%
Alexion Pharmaceuticals Inc USA 5.09%
Vertex Pharmaceuticals Inc USA 4.71%
Gilead Sciences Inc USA 4.66%
Seattle Genetics Inc USA 3.85%
Incyte Corp USA 3.65%
Illumina Inc USA 3.17%
Biomarin Pharmaceutical Inc USA 3.10%

Currently unavailable